David Henry

Hematologist Oncologist🩸 | Vice Chair Dept of Medicine Pennsylvania Hospital | Blood&Cancer host Research-supportive care @MDedgeTweets @MDedgeHemeOnc

[David Henry @davidhenrymd]

Phase 3 trial investigating teclistamab + daratumumab use for multiple myeloma shows improved progression free survival and overall survival @MDedgeHemOnc
https://t.co/AJZBJF9Kd1

[David Henry @davidhenrymd]

Study finds favorable objective response rates for use of Trastuzumab-Deruxtecan in patients with ERBB2-Mutant NSCLC @MDedgeHemOnc
https://t.co/a5p8BWpkXg

[David Henry @davidhenrymd]

Recent chemotherapy drug shortages have negatively impacted patient care @MDedgeHemOnc
https://t.co/KiRYKaF222

[David Henry @davidhenrymd]

Addition of #Lenvatinib to standard treatment of esophageal squamous cell carcinoma did not show survival benefit @MDedgeHemOnc
https://t.co/64ePVgQg1d

[David Henry @davidhenrymd]

Pola-R-CHP shows improved progression free survival over R-CHOP at 5 years for treatment of #DLBCL @MDedgeHemOnc
https://t.co/2EtDXTfGhA

[David Henry @davidhenrymd]

Study found no difference in quality of life and side effects between radiation and proton therapies in #OropharyngealCancer @MDedgeHemOnc
https://t.co/rIe3ON74PG

[David Henry @davidhenrymd]

Ropeginterferon may be a potential treatment option for patients with essential thrombocythemia @MDedgeHemOnc
https://t.co/1uU05wdF4c

[David Henry @davidhenrymd]

Phase 3 Trial finds that Ivonescimab improves progression free survival for patients with EGFR-mutated non-small cell lung cancer @MDedgeHemOnc
https://t.co/jGlkoiE5Hm

[David Henry @davidhenrymd]

Study found improved overall survival with statin use for patients taking apalutamide for #ProstateCancer @MDedgeHemOnc
https://t.co/yuJXTvu5Iy

[David Henry @davidhenrymd]

Potential improvements in biochemical disease-free survival with use of focal radiation for #ProstateCancer @MDedgeHemOnc
https://t.co/eY6RYl4ihf

[David Henry @davidhenrymd]

Study found that #Itacitinib use prior to immune effector cell therapy resulted in decreased incidence of cytokine release syndrome @MDedgeHemOnc
https://t.co/H93x42ZYGK

[David Henry @davidhenrymd]

Association between alcohol use and #PancreaticCancer risk may be higher than previously thought @MDedgeHemOnc
https://t.co/PrTiFGbO8k

[David Henry @davidhenrymd]

Study highlights links between #LungCancer and Interstitial Lung Disease @MDedgeHemOnc
https://t.co/ezMkHtWa1g

[David Henry @davidhenrymd]

#GallbladderCancer and #Cholangiocarcinoma: Improved outcomes with use of #Camrelizumab as part of triple therapy
https://t.co/kGYSVGJMml

[David Henry @davidhenrymd]

Study comparing therapies for right-sided metastatic #ColonCancer @MDedgeHemOnc
https://t.co/O4EE5jWa7M

[David Henry @davidhenrymd]

Resistance training may improve lymphedema for patients with #BreastCancer @MDedgeHemOnc

https://t.co/2c3oBLiTj1

[David Henry @davidhenrymd]

Potential improvements in complete response rates using Sintilimab with standard treatment regimen for #HodgkinLymphoma @MDedgeHemOnc
https://t.co/HHtND0HxUp

[David Henry @davidhenrymd]

Improving Outcomes➡️Addition of #Niraparib for metastatic, hormone-sensitive prostate cancer with HRR gene alterations may slow progression @MDedgeHemOnc #ProstateCancer
https://t.co/eUkzIFuP96

[David Henry @davidhenrymd]

Impact of Breast Cancer Treatment on Musicality
@MDedgeHemOnc #BreastCancer #Musicians
https://t.co/8Cyu0HZ2dD

[David Henry @davidhenrymd]

#Prevention of obesity-related cancers using #GLP-1s
@MDedgeHemOnc
https://t.co/6J3llGrNcy